Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

Addressing Cancer-Related Financial Toxicity in Rural Oncology Care Settings

ClinicalTrials.gov ID: NCT04931251

Public ClinicalTrials.gov record NCT04931251. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 8, 2026, 4:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Addressing Cancer-Related Financial Toxicity in Rural North Carolina Oncology Care Settings

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The financial burden, or financial toxicity (FT), of cancer is a consequential and growing problem, particularly for rural patients. It is important to improve our understanding of how financial navigation (FN) can reduce the material, psychological, and behavioral burden of costs associated with cancer care in both rural and non-rural community settings. The purpose of this study is to conduct a financial navigation program in 5 rural and 4 non-rural oncology practices in North Carolina and evaluate the effects of financial navigation on patient outcomes, including financial toxicity and health-related quality of life.

Study identification

NCT ID
NCT04931251
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Enrollment
258 participants

Conditions and interventions

Interventions

Behavioral

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 10, 2021
Primary completion
Jul 30, 2025
Completion
Jul 30, 2025
Last update posted
Nov 25, 2025

2021 – 2025

United States locations

U.S. sites
8
U.S. states
1
U.S. cities
8
Facility City State ZIP Site status
NC Basnight Cancer Hospital Chapel Hill North Carolina 27514
Novant Health Charlotte North Carolina 28207
Vidant Medical Center, Cancer Center Greenville North Carolina 27834
Pardee UNC Health Care, Pardee Cancer Center Hendersonville North Carolina 28739
UNC Lenoir Cancer Care Services Kinston North Carolina 28501
Carteret Health Care Cancer Center Morehead City North Carolina 28557
The Outer Banks Hospital Nags Head North Carolina 27959
Wake Forest University Health Sciences Winston-Salem North Carolina 27157

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04931251, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 25, 2025 · Synced Sep 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04931251 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →